Scleroderma is not curable it can be considerably controlled with treatment methods that are aimed at the various symptoms that ravage the patient’s body. In some patients, the treatment could be ...

The Systemic scleroderma treatment market expected to reach USD 2.2 billion by 2030 according to a new study by Report Ocean. The report “Systemic Scleroderma Treatment Market Report, By Drug Class ...

Scleroderma is an intricate autoimmune disease wherein one notices the hardening and tightening of the skin and connective tissues. Here, the immune system causes inflammation and injury to the cells ...

UVA researcher Blandine Baffert, working in the lab of UVA Health’s Sanja Arandjelovic and collaborating with researchers in ...

What is the latest research on scleroderma? Find out in this collection of recent MEDLINE abstracts compiled by the editors at Medscape Nurses. Acute and chronic renal diseases remain common ...

DelveInsight's, “Scleroderma Pipeline Insight 2025” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Scleroderma pipeline landscape. It covers the Scleroderma ...

Dublin, Sept. 29, 2023 (GLOBE NEWSWIRE) -- The "Scleroderma Diagnostics and Therapeutics: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global ...

The "Systemic Scleroderma Treatment Market Share, Size, Trends, Industry Analysis Report, By Drug Class; By Regions; Segment Forecast, 2021-2028" report has been added to ResearchAndMarkets.com’s ...

Report Ocean presents a new report on Systemic scleroderma treatment market size, share, growth, industry trends, and forecast 2030, covering various industry elements and growth trends helpful for ...

The New Zealand Scleroderma Group is calling for the introduction of a monitoring and treatment programme for New Zealanders with scleroderma to mark World Scleroderma Day on June 29. Scleroderma is ...